Mazen Nasrallah

Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy

Mauro Di Pilato, Edward Y. Kim, Bruno L. Cadilha et al. · Nature · 2019 · 202 citations · Full text

Cancer Immunosurveillance, T-regulatory Cell, Immunology +10

Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience

Meghan J. Mooradian, Mazen Nasrallah, Justin F. Gainor et al. · Seminars in Arthritis and Rheumatism · 2018 · 100 citations

Rheumatoid Disorder, Rheumatology, Vasculitis +15

Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018

Gabriel E. Molina, Leyre Zubiri, Justine V. Cohen et al. · The Oncologist · 2021 · 45 citations · Full text

Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis

Molly Thomas, Kamil Slowikowski, Kasidet Manakongtreecheep et al. · Nature Medicine · 2024 · 42 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Cytokine +13

Predictors of Rheumatic <scp>Immune‐Related</scp> Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for Cancer

Amy Cunningham‐Bussel, Jiaqi Wang, Lauren Prisco et al. · Arthritis & Rheumatology · 2021 · 40 citations · Full text